12.4 Catalysis and enzyme kinetics

Catalysts and Reaction Rates

The Role of Catalysts in Chemical Reactions

A catalyst speeds up a chemical reaction without being consumed in the process. It does this by providing an alternative reaction pathway that has a lower activation energy than the uncatalyzed route.

Here's how that works mechanistically: the catalyst interacts with the reactants to form an intermediate complex, which then decomposes to yield products and regenerate the catalyst. Because the catalyst is regenerated, it can participate in many reaction cycles.

The key quantitative point is that a catalyst lowers $E_a$ (the activation energy), which increases the rate constant $k$ through the Arrhenius equation:

$k = A e^{-E_a / RT}$

Even a modest decrease in $E_a$ produces a large increase in $k$ because of that exponential dependence.

Catalysts and Reaction Equilibrium

A catalyst does not change the equilibrium constant $K$ or the thermodynamics ($\Delta G$, $\Delta H$) of a reaction. It accelerates both the forward and reverse reactions equally, so the system reaches equilibrium faster but settles at the same position.

• Catalysts are often highly specific to particular reactions or classes of reactions.
• Their effectiveness can be influenced by temperature, pressure, and the presence of inhibitors or promoters.
• Industrial examples: the Haber-Bosch process (iron catalyst for $\text{N}_2 + 3\text{H}_2 \rightarrow 2\text{NH}_3$), the Contact process ($\text{V}_2\text{O}_5$ catalyst for $\text{SO}_3$ production), and hydrocarbon cracking in petroleum refining.

Homogeneous vs. Heterogeneous Catalysis

Homogeneous Catalysis

In homogeneous catalysis, the catalyst and reactants exist in the same phase (both in solution, or both in the gas phase). The catalyst is uniformly distributed throughout the reaction mixture, so every reactant molecule has equal access to it.

• Examples: acid/base catalysis in aqueous solution, organometallic complexes (e.g., Wilkinson's catalyst for hydrogenation), and enzymes operating in the aqueous environment of a cell.
• Advantage: uniform mixing often gives high selectivity and reproducible kinetics.
• Disadvantage: separating the catalyst from the product mixture can be difficult.

Heterogeneous Catalysis

In heterogeneous catalysis, the catalyst and reactants are in different phases. Most commonly, the catalyst is a solid and the reactants are gases or liquids. The reaction occurs at the catalyst surface through a sequence of steps:

1. Adsorption of reactant molecules onto the catalyst surface.
2. Surface reaction between adsorbed species (or between an adsorbed species and a gas-phase molecule).
3. Desorption of product molecules from the surface.

• Examples: platinum and palladium surfaces (automotive catalytic converters), metal oxides like alumina and silica, and zeolites (petroleum cracking).
• Advantages: easy separation from the reaction mixture, potential for regeneration and reuse, and tolerance of high temperatures and pressures.
• A major concern is mass transfer limitation: reactants must diffuse to the catalyst surface before they can react. Using high-surface-area materials (nanoparticles, porous supports) helps minimize this bottleneck.

Enzyme Kinetics and the Michaelis-Menten Model

Enzymes as Biological Catalysts

Enzymes are proteins that catalyze reactions in biological systems. They are remarkably specific, typically catalyzing only one reaction (or a narrow class of reactions) involving particular substrates. Like all catalysts, they lower $E_a$ and are regenerated at the end of each catalytic cycle.

The Michaelis-Menten Model

The Michaelis-Menten model describes how the rate of an enzyme-catalyzed reaction depends on substrate concentration. The basic mechanism is:

$E + S \underset{k_{-1}}{\overset{k_1}{\rightleftharpoons}} ES \overset{k_2}{\rightarrow} E + P$

The enzyme ($E$) binds the substrate ($S$) to form an enzyme-substrate complex ($ES$), which then breaks down to release product ($P$) and free enzyme.

Applying the steady-state approximation (the concentration of $ES$ stays roughly constant after an initial transient) gives the Michaelis-Menten equation:

$v = \frac{V_{\max}[S]}{K_m + [S]}$

where:

• $v$ = observed reaction rate
• $V_{\max}$ = maximum rate when all enzyme active sites are saturated
• $[S]$ = substrate concentration
• $K_m$ = Michaelis constant, defined as $K_m = \frac{k_{-1} + k_2}{k_1}$

Interpreting $K_m$: It equals the substrate concentration at which $v = V_{\max}/2$. A lower $K_m$ means the enzyme reaches half-maximal velocity at a lower $[S]$, indicating higher apparent affinity for the substrate.

Interpreting $V_{\max}$: It is proportional to total enzyme concentration: $V_{\max} = k_{\text{cat}}[E]_0$, where $k_{\text{cat}}$ (the catalytic constant or turnover number) is the number of substrate molecules converted to product per enzyme molecule per unit time.

Lineweaver-Burk Plot

The Michaelis-Menten equation is a hyperbola, which makes it hard to extract $K_m$ and $V_{\max}$ directly from a $v$ vs. $[S]$ curve. Taking the reciprocal of both sides linearizes it:

$\frac{1}{v} = \frac{K_m}{V_{\max}} \cdot \frac{1}{[S]} + \frac{1}{V_{\max}}$

Plotting $1/v$ against $1/[S]$ (the Lineweaver-Burk or double-reciprocal plot) gives a straight line with:

• y-intercept = $1/V_{\max}$
• x-intercept = $-1/K_m$
• slope = $K_m / V_{\max}$

This plot is especially useful for distinguishing types of inhibition (see below), since each type distorts the line differently.

Factors Affecting Enzyme Activity

Substrate and Enzyme Concentration

Substrate concentration: At low $[S]$, the rate increases nearly linearly with $[S]$ (first-order behavior). As $[S]$ grows, the rate curves and eventually plateaus at $V_{\max}$ (zero-order behavior) because all enzyme active sites are occupied.

Enzyme concentration: At fixed (and saturating) $[S]$, increasing $[E]_0$ increases $v$ proportionally, since $V_{\max} = k_{\text{cat}}[E]_0$. If substrate is limiting, though, adding more enzyme won't help because there isn't enough $S$ to keep the extra enzyme occupied.

Enzyme Inhibitors

Inhibitors reduce enzyme activity, and the three classical reversible types are distinguished by where they bind and how they affect the Lineweaver-Burk plot:

• Competitive inhibitors bind to the active site, competing directly with the substrate. They increase the apparent $K_m$ (you need more substrate to outcompete the inhibitor) but leave $V_{\max}$ unchanged. On a Lineweaver-Burk plot, the lines for different inhibitor concentrations share the same y-intercept but have different slopes and x-intercepts.
• Non-competitive inhibitors bind at a site other than the active site, on either the free enzyme or the enzyme-substrate complex. They decrease the apparent $V_{\max}$ (fewer functional enzyme molecules) without changing $K_m$. On a Lineweaver-Burk plot, the x-intercept stays the same but the y-intercept and slope both increase.
• Uncompetitive inhibitors bind only to the $ES$ complex, not to the free enzyme. They decrease both the apparent $V_{\max}$ and the apparent K_m}. On a Lineweaver-Burk plot, this produces parallel lines (same slope, different intercepts).

Allosteric Regulation

Some enzymes have allosteric sites distinct from the active site. Molecules that bind these sites can modulate enzyme activity:

• Allosteric activators stabilize the active conformation, increasing catalytic efficiency.
• Allosteric inhibitors stabilize an inactive conformation, reducing activity.

Allosteric regulation is common in metabolic pathways, where end-product inhibition (feedback inhibition) prevents overproduction of a metabolite.

Catalysis in Real-World Applications

Industrial Processes

Catalysts are central to large-scale chemical manufacturing. They increase reaction rates, improve selectivity, and reduce the energy input needed.

• Haber-Bosch process: Iron-based catalyst enables $\text{N}_2 + 3\text{H}_2 \rightarrow 2\text{NH}_3$ at feasible temperatures and pressures.
• Catalytic converters: Platinum, palladium, and rhodium surfaces convert $\text{CO}$, $\text{NO}_x$, and unburned hydrocarbons into $\text{CO}_2$, $\text{N}_2$, and $\text{H}_2\text{O}$.
• Zeolites in petroleum cracking: Porous aluminosilicate frameworks catalyze the breaking of long-chain hydrocarbons into shorter, more useful fractions.

Biological Systems

Enzymes catalyze virtually every reaction in living cells:

• Digestive enzymes (amylase, pepsin, lipase) break macronutrients into absorbable molecules.
• Metabolic enzymes in glycolysis and the citric acid cycle drive energy production.
• DNA and RNA polymerases catalyze nucleic acid synthesis during replication and transcription.

Drug Development and Enzyme Engineering

Many pharmaceutical drugs work by inhibiting specific enzymes. For example, statins are competitive inhibitors of HMG-CoA reductase, the enzyme that controls cholesterol biosynthesis. Understanding $K_m$, $V_{\max}$, and inhibition type is directly relevant to rational drug design.

Enzyme engineering (via directed evolution or site-directed mutagenesis) can tailor catalytic properties for industrial biocatalysis, producing biofuels, pharmaceuticals, or fine chemicals with high selectivity under mild conditions.

Biosensors

Enzymes immobilized on surfaces can serve as highly selective detectors. Glucose oxidase, for instance, is the sensing element in blood glucose monitors used by people with diabetes. The enzyme converts glucose to gluconolactone, generating a measurable electrical signal proportional to glucose concentration.